ProPhase Labs Stock Forecast for 2023 - 2025 - 2030

Updated on 04/19/2024

Stock Rating
13
Price Target
$20.00
Consensus
Upside
267.65%
Analysts
2
Stock Rating
13
Upside
267.65%
Analysts
2
Price Target
$20.00

ProPhase Labs Stock Forecast and Price Target

The average target price set lately by two experts for ProPhase Labs to reach by the end of the year is $20.00, which would imply a potential upside of approximately 267.65 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $20.00 and a low estimate of $20.00. Even if not interested in PRPH stock, you may want to be aware of its competitors.

$20.00

267.65% Upside

ProPhase Labs Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, ProPhase Labs's Price has decreased from $0.94 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $5.87 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$5.87
2025 Fair Value Forecast
$6.52
2026 Fair Value Forecast
$7.25
2027 Fair Value Forecast
$8.06
2028 Fair Value Forecast
$8.97
2029 Fair Value Forecast
$9.97
2030 Fair Value Forecast
$11.08

ProPhase Labs Revenue Forecast for 2023 - 2025 - 2030

ProPhase Labs's Revenue has seen impressive growth In the last two years, rising from $14.51M to $122.65M – a growth of 745.28%. In the following year, 2 experts forecast that ProPhase Labs's Revenue will decrease by 34.25%, to $80.64M. In 2030, professionals predict that ProPhase Labs's Revenue will decrease by 1.46%, to $120.87M.

2024 Rev Forecast
$0.08B
2025 Rev Forecast
$0.13B
2026 Rev Forecast
$0.12B
2027 Rev Forecast
$0.13B
2028 Rev Forecast
$0.11B
2029 Rev Forecast
$0.12B
2030 Rev Forecast
$0.12B

ProPhase Labs Dividend per Share Forecast for 2023 - 2025 - 2030

ProPhase Labs Free Cash Flow Forecast for 2023 - 2025 - 2030

ProPhase Labs EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, ProPhase Labs's EBITDA has seen an increase, rising from $-3.54M to $28.31M. This represents a growth of 899.72%. In the following year, the 0 analysts surveyed believe that ProPhase Labs's EBITDA will decrease by 78.34%, reaching $6.13M. According to professionals, by 2030, ProPhase Labs's EBITDA will have decreased by 6.25%, falling down to $26.54M.

2023 EBITDA Forecast
$0.01B
2024 EBITDA Forecast
$0.01B
2025 EBITDA Forecast
$0.02B
2026 EBITDA Forecast
$0.04B
2027 EBITDA Forecast
$0.02B
2028 EBITDA Forecast
$0.02B
2029 EBITDA Forecast
$0.02B
2030 EBITDA Forecast
$0.03B

ProPhase Labs EBIT Forecast for 2023 - 2025 - 2030

ProPhase Labs's EBIT has seen growth In the last two years, going from $-3.99M to $23.60M – a gain of 691.48% The next year, 2 experts forecast that ProPhase Labs's EBIT will decrease by 109.87%, reaching $-2.33M. For the next seven years, the forecast is forEBIT to grow by 1752.74%.

2024 EBIT Forecast
$-2330000.00
2025 EBIT Forecast
$0.01B
2026 EBIT Forecast
$0.02B
2027 EBIT Forecast
$0.09B
2028 EBIT Forecast
$0.00B
2029 EBIT Forecast
$0.03B
2030 EBIT Forecast
$0.44B

ProPhase Labs EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, ProPhase Labs's EPS has decreased from $0.40 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $-0.18 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$-0.18
2025 EPS Forecast
$-0.32
2026 EPS Forecast
$-0.28
2027 EPS Forecast
$-0.16
2028 EPS Forecast
$-0.18
2029 EPS Forecast
$-0.23
2030 EPS Forecast
$-0.26